糖尿病认知障碍的机制和病变:全面的审查
Chang Qi1, Ming Qin2, Yu Wang2
1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Aging and disease
|September 16, 2025
概括
糖尿病认知障碍 (DCI) 影响了许多患有糖尿病的老年人,影响了记忆力和注意力. 了解DCI 的理解
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
背景情况:
- 糖尿病认知障碍 (DCI) 是一种影响记忆,学习和注意力的糖尿病并发症.
- 患病率随着年龄的增长而增加,对65-74岁的人群影响13%,75岁以上的人群影响24%.
- 越来越多的DCI发病率带来了重大的经济和护理挑战.
研究的目的:
- 系统地审查关于DCI机制和病理变化的现有研究.
- 探索代谢障碍和认知衰退之间的不清楚因果关系.
- 为了解决糖尿病患者中DCI发展的异质性.
主要方法:
- 对DCI研究的系统性文献综述.
- 病理过程和神经退行性联系的分析.
- 基本科学发现与临床实践的整合.
主要成果:
- DCI涉及到记忆,学习,语言,运动技能,感知和注意力的缺陷.
- 目前尚不清楚高血糖是否直接损害神经元或间接导致血管损伤.
- 个人在DCI进展中的异质性仍然是一个关键问题.
结论:
- 了解DCI机制对于早期预防和治疗至关重要.
- DCI强调了代谢和神经退行性疾病的交集.
- 建议将认知评估整合到糖尿病管理中.
相关概念视频
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868


